Literature DB >> 1897931

A comparison of phospholipid degradation by oxidation and hydrolysis during the mitochondrial permeability transition.

W L Erdahl1, R J Krebsbach, D R Pfeiffer.   

Abstract

The peroxidation and hydrolysis of mitochondrial phospholipids has been examined under conditions which are referable to induction of the permeability transition by t-butylhydroperoxide. Over a 30-min time course, the peroxide causes formation of 0.3 nmol/mg protein of malondialdehyde. This value is little effected by Ca2+, Sr2+, or Mn2+ but is increased approximately fivefold by Fe2+. The latter cation, but not the others, results in malondialdehyde formation in the absence of added peroxide. Partially oxidized phosphatidylethanolamine is present in normal mitochondria and is increased by approximately 50% following t-butylhydroperoxide treatment; however, the amounts observed are in the range of 0.4-0.6 mol% of total phosphatidylethanolamine. The minor degradation by peroxidation is in contrast to approximately 2.5 mol% degradation which occurs by hydrolysis. This degree of hydrolysis is accompanied by mitochondrial swelling and Mg2+ release, while a comparable level of peroxidation (malondialdehyde formation) is not. It is concluded that induction of the permeability transition by t-butylhydroperoxide does not represent damage to the membrane lipid phase caused by peroxidation. It is possible, however, that peroxidation accelerates the accumulation of phospholipid hydrolysis products and is thereby a factor which favors the transition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1897931     DOI: 10.1016/0003-9861(91)90357-o

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Low-density lipoprotein-mediated delivery of docosahexaenoic acid selectively kills murine liver cancer cells.

Authors:  Lacy Reynolds; Rohit S Mulik; Xiaodong Wen; Archana Dilip; Ian R Corbin
Journal:  Nanomedicine (Lond)       Date:  2014-01-07       Impact factor: 5.307

2.  Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells.

Authors:  Lacy R Moss; Rohit S Mulik; Tim Van Treuren; Soo Young Kim; Ian R Corbin
Journal:  Biochim Biophys Acta       Date:  2016-07-11

3.  Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound.

Authors:  Rohit S Mulik; Chenchen Bing; Michelle Ladouceur-Wodzak; Imalka Munaweera; Rajiv Chopra; Ian R Corbin
Journal:  Biomaterials       Date:  2016-01-06       Impact factor: 12.479

4.  Involvement of intracellular Ca2+ and K+ in dissipation of the mitochondrial membrane potential and cell death induced by extracellular ATP in hepatocytes.

Authors:  J P Zoeteweij; B van de Water; H J de Bont; G J Mulder; J F Nagelkerke
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

5.  An integrated systems-level model of ochratoxin A toxicity in the zebrafish (Danio rerio) embryo based on NMR metabolic profiling.

Authors:  Muhamed N H Eeza; Narmin Bashirova; Zain Zuberi; Jörg Matysik; John P Berry; A Alia
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.996

6.  Assessing the safety of transarterial locoregional delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat liver.

Authors:  Junjie Li; Diana Canseco; Yuzhu Wang; Gonçalo Vale; Jaideep Chaudhary; Arnida Anwar; Hamid Baniasadi; Noelle S Williams; Purva Gopal; Patrick D Sutphin; Jeffrey G McDonald; William C Putnam; Ian R Corbin
Journal:  Eur J Pharm Biopharm       Date:  2020-11-24       Impact factor: 5.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.